NL-OMON44974已完成不适用
Galectin-1 and -3 as biomarkers for capsular contracture. A pilot study - Galectin-1 and -3 as biomarkers for capsular contracture
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational non invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- females aged 18 or over
- •- females who have developed capsular contracture (Baker score 1&2 and 3&4) after bilateral cosmetic breast augmentation with silicone breast implants at least one year after implant implantation
- •- females who who are on the waiting list for a breast augmentation will serve as a control group
排除标准
- •- females who have a co-morbidity (e.g. diseases of the liver, lung, heart, kidney, or skin);
- •- females who have (a history of) cancer
- •- females who have a capsular contracture for more than 5 years
- •- females who have had silicone injections
- •- females who are currently smoking or smoked in the past year
研究者
相似试验
进行中（未招募）
不适用
se of galectin-3 as a blood marker for patients with Chagas disease.Chronic Chagas Disease with cardiac involvementB57.2RBR-5m6748Hospital São Rafael
已完成
不适用
Galectin-3 as a Biomarker in Patients With Chagas DiseaseChagas DiseaseNCT01842854Hospital Sao Rafael60
尚未招募
不适用
Galectin-3 and oral submucous fibrosisCTRI/2020/12/029928Dr Hetvi Sheth
已完成
不适用
Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patientson-small cell lung cancerJPRN-UMIN000026869Shiga University of Medical Science250
招募中
不适用
Study of galectin-9 as novel biomarker of activity and therapeutic agent in IgA nephropathyIgA nephropathyJPRN-UMIN000015551Kagawa University Hospital30